Journal Information
Most often read
38652
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of actionAlexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
38652
Full text access
9662
Liver diseases: Perspective from the PhilippinesEric David Ornos, Karl Jeffrey Murillo, Janus P. Ong
Ann Hepatol. 2023;28:101085
9662
Full text access
7589
Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectivesRoberta Gagliardi, Nicola Zeni, Salvatore Piano
Ann Hepatol. 2023;28:101150
7589
Full text access
7492
What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco
Ann Hepatol. 2023;28:100874
7492
Open access
5618
A thorny matter: Spur cell anemiaRuchi Sharma, Carol J. Holman, Kyle E. Brown
Ann Hepatol. 2023;28:100771
5618
Open access
4757
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M. Irvine, Suzanne Williams, Gaurav Puri, ... Elizabeth E. Powell
Ann Hepatol. 2023;28:101142
4757
Full text access
4596
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLDLouise Torres, Alice Schuch, Larisse Longo, Bruna Bressan Valentini, Gabriela Schneider Galvão, Eduardo Luchese, Carlos Pinzon, Rodrigo Bartels, Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100774
4596
Open access
3767
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of HepatologyAldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas, María Sarai González-Huezo, José Luís Pérez-Hernández, Osvely Méndez-Guerrero, ... Francisco Alfonso Solís-Galindo
Ann Hepatol. 2023;28:101140
3767
Full text access
2899
Immunotolerance in liver transplantation: a primer for the clinicianJuanita Pérez-Escobar, Jose Victor Jimenez, Erika Faride Rodríguez-Aguilar, Maximiliano Servín-Rojas, Jesus Ruiz-Manriquez, Luisa Safar-Boueri, Eduardo Carrillo-Maravilla, Miquel Navasa, Ignacio García-Juárez
Ann Hepatol. 2023;28:100760
2899
Open access
2673
Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosisHaotang Ren, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhongji Meng, ... Yu Shi
Ann Hepatol. 2023;28:101147
2673
Full text access
2661
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysisDaniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
2661
Open access
![](https://static.elsevier.es/multimedia/16652681/0000002800000001/v2_202303281200/S1665268122002150/v2_202303281200/en/main.assets/ga1.jpeg)
2623
Body weight loss and glycemic control on the outcomes of patients with NAFLD. The role of new antidiabetic agentsDiego García-Compeán, Ramesh Kumar, Ángel Noe del Cueto-Aguilera, Héctor Jesús Maldonado-Garza, Jesús Zacarías Villarreal-Pérez
Ann Hepatol. 2023;28:100751
2623
Full text access
2141
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
2141
Open access
![](https://static.elsevier.es/multimedia/16652681/0000002800000001/v2_202303281200/S1665268122001041/v2_202303281200/en/main.assets/ga1.jpeg)
1981
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective studyYongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan
Ann Hepatol. 2023;28:101099
1981
Full text access
1839
The treatment of diabetes in advanced liver disease: change of a paradigmMaria Letizia Petroni, Lucia Brodosi, Giulio Marchesini
Ann Hepatol. 2023;28:100772
1839
Open access
1793
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanismsXiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou
Ann Hepatol. 2023;28:101121
1793
Full text access
1741
Metabolic dysfunction: The silenced connection with fatty liver diseaseMariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
1741
Full text access
1699
Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver diseaseJing Liu, Haifeng Lv, Jie Wang, Qianru Zhu, Gongying Chen, Yanming Jiang, Ke Zhao, Li Shao, ... Xiaoben Pan
Ann Hepatol. 2023;28:100892
1699
Full text access
1555
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhoticsItamar Krispin, Mahmud Mahamid, Eran Goldin, Bashar Fteiha
Ann Hepatol. 2023;28:100897
1555
Full text access
1537
Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortalityMahak Chauhan, Talan Zhang, Paul J. Thuluvath
Ann Hepatol. 2023;28:101084
1537
Full text access